These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32450494)

  • 1. Prognostic impact of cancer-associated active fibroblasts and invasive architectural patterns on early-stage lung adenocarcinoma.
    Yotsukura M; Asamura H; Suzuki S; Asakura K; Yoshida Y; Nakagawa K; Sakurai H; Watanabe SI; Motoi N
    Lung Cancer; 2020 Jul; 145():158-166. PubMed ID: 32450494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinoma.
    Murakami S; Ito H; Tsubokawa N; Mimae T; Sasada S; Yoshiya T; Miyata Y; Yokose T; Okada M; Nakayama H
    Lung Cancer; 2015 Nov; 90(2):199-204. PubMed ID: 26341957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease.
    Kadota K; Villena-Vargas J; Yoshizawa A; Motoi N; Sima CS; Riely GJ; Rusch VW; Adusumilli PS; Travis WD
    Am J Surg Pathol; 2014 Apr; 38(4):448-60. PubMed ID: 24472852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histological and prognostic data on surgically resected early-stage lung adenocarcinoma.
    Yotsukura M; Asamura H; Suzuki S; Asakura K; Yoshida Y; Nakagawa K; Sakurai H; Watanabe SI; Motoi N
    Data Brief; 2020 Aug; 31():105785. PubMed ID: 32551350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the histologic predominance of pathological stage IA lung adenocarcinoma influence the extent of resection?
    Ito H; Nakayama H; Murakami S; Yokose T; Katayama K; Miyata Y; Okada M
    Gen Thorac Cardiovasc Surg; 2017 Sep; 65(9):512-518. PubMed ID: 28593420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact according to the proportion of the lepidic subtype in stage IA acinar-predominant lung adenocarcinoma.
    Jeon HW; Kim YD; Sim SB; Moon MH
    Thorac Cancer; 2021 Jul; 12(14):2072-2077. PubMed ID: 34033216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors of acinar- or papillary-predominant adenocarcinoma of the lung.
    Kim M; Chung YS; Kim KA; Shim HS
    Lung Cancer; 2019 Nov; 137():129-135. PubMed ID: 31586770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of malignant grade between pure and partially invasive types of early lung adenocarcinoma.
    Sasada S; Nakayama H; Miyata Y; Tsubokawa N; Mimae T; Yoshiya T; Murakami S; Ito H; Okada M
    Ann Thorac Surg; 2015 Mar; 99(3):956-60. PubMed ID: 25620597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonpredominant lepidic pattern correlates with better outcome in invasive lung adenocarcinoma.
    Mäkinen JM; Laitakari K; Johnson S; Mäkitaro R; Bloigu R; Lappi-Blanco E; Kaarteenaho R
    Lung Cancer; 2015 Dec; 90(3):568-74. PubMed ID: 26506915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excellent prognosis of lepidic-predominant lung adenocarcinoma: low incidence of lymphatic vessel invasion as a key factor.
    Araki K; Kidokoro Y; Hosoya K; Wakahara M; Matsuoka Y; Takagi Y; Haruki T; Miwa K; Taniguchi Y; Horie S; Nakamura H
    Anticancer Res; 2014 Jun; 34(6):3153-6. PubMed ID: 24922687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant difference in recurrence according to the proportion of high grade patterns in stage IA lung adenocarcinoma.
    Jeon HW; Kim YD; Sim SB; Moon MH
    Thorac Cancer; 2021 Jul; 12(13):1952-1958. PubMed ID: 34037324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society lung adenocarcinoma classification on death and recurrence in completely resected stage I lung adenocarcinoma.
    Hung JJ; Jeng WJ; Chou TY; Hsu WH; Wu KJ; Huang BS; Wu YC
    Ann Surg; 2013 Dec; 258(6):1079-86. PubMed ID: 23532112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second predominant subtype predicts outcomes of intermediate-malignant invasive lung adenocarcinoma†.
    Ito M; Miyata Y; Yoshiya T; Tsutani Y; Mimura T; Murakami S; Ito H; Nakayama H; Okada M
    Eur J Cardiothorac Surg; 2017 Feb; 51(2):218-222. PubMed ID: 28186287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Validation of prognostic value of pathological staging in pathological stage Ⅰ lung adenocarcinoma].
    Zhang H; Sun FH; Chen ZC; Wang Q
    Zhonghua Wai Ke Za Zhi; 2022 Jun; 60(6):580-586. PubMed ID: 35658346
    [No Abstract]   [Full Text] [Related]  

  • 15. Correlation of histological components with tumor invasion in pulmonary adenocarcinoma.
    Moon Y; Kim KS; Sung SW; Lee KY; Kim YK; Kang JH; Kim YS; Park JK
    World J Surg Oncol; 2014 Dec; 12():388. PubMed ID: 25519483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenocarcinomas with prominent lepidic spread: retrospective review applying new classification of the American Thoracic Society.
    Xu L; Tavora F; Battafarano R; Burke A
    Am J Surg Pathol; 2012 Feb; 36(2):273-82. PubMed ID: 22198010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minor histological components predict the recurrence of patients with resected stage I acinar- or papillary-predominant lung adenocarcinoma.
    Liu W; Zhang Q; Zhang T; Li L; Xu C
    Front Oncol; 2022; 12():1090544. PubMed ID: 36620572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid predominant histologic subtype and early recurrence predict poor postrecurrence survival in patients with stage I lung adenocarcinoma.
    Luo J; Wang R; Han B; Zhang J; Zhao H; Fang W; Luo Q; Yang J; Yang Y; Zhu L; Chen T; Cheng X; Huang Q; Wang Y; Zheng J; Chen H
    Oncotarget; 2017 Jan; 8(4):7050-7058. PubMed ID: 27732964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stromal invasion and micropapillary pattern in 212 consecutive surgically resected stage I lung adenocarcinomas: histopathological categories for prognosis prediction.
    Yeh YC; Wu YC; Chen CY; Wang LS; Hsu WH; Chou TY
    J Clin Pathol; 2012 Oct; 65(10):910-8. PubMed ID: 22813729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung Adenocarcinoma Staging Using the 2011 IASLC/ATS/ERS Classification: A Pooled Analysis of Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma.
    Behera M; Owonikoko TK; Gal AA; Steuer CE; Kim S; Pillai RN; Khuri FR; Ramalingam SS; Sica GL
    Clin Lung Cancer; 2016 Sep; 17(5):e57-e64. PubMed ID: 27137345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.